Hemangeol
Hemangeol
Hemangeol (pronunciation: /hɪˈmændʒiːɒl/) is a medication used in the treatment of infantile hemangioma, a common benign vascular tumor that occurs in infancy.
Etymology
The term "Hemangeol" is a combination of "hema-" from the Greek "haima" meaning blood, and "-geol" from the Greek "geolas" meaning earth. This is in reference to the medication's use in treating blood vessel growths.
Usage
Hemangeol is a beta blocker that works by narrowing the blood vessels in the body, thereby reducing blood flow to the hemangioma. It is typically administered orally and is used in infants aged 5 weeks to 5 months.
Related Terms
- Infantile Hemangioma: A benign vascular tumor that occurs in infancy, typically appearing in the first or second week of life. It grows rapidly for up to a year and then slowly regresses.
- Beta Blocker: A class of medications that are particularly used to manage abnormal heart rhythms, and to protect the heart from a second heart attack after a first heart attack.
- Propranolol: The active ingredient in Hemangeol, a non-selective beta blocker that reduces the heart rate, the force of the heart muscle's contractions, and the blood pressure in the arteries.
External links
- Medical encyclopedia article on Hemangeol
- Wikipedia's article - Hemangeol
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski